We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
Turnover
90.24%
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.1%
AUM
$585M
AUM Growth
+$56.2M
(+11%)
Cap. Flow
+$17.6M
Cap. Flow
% of AUM
3.01%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
830
New
329
Increased
104
Reduced
143
Closed
252
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$33.9M |
| 2 |
Verizon
VZ
|
+$6.56M |
| 3 |
Lowe's Companies
LOW
|
+$6.21M |
| 4 |
Procter & Gamble
PG
|
+$6.15M |
| 5 |
Danaher
DHR
|
+$5.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$12.8M |
| 2 |
Meta Platforms (Facebook)
META
|
+$11.3M |
| 3 |
Apple
AAPL
|
+$11.1M |
| 4 |
UnitedHealth
UNH
|
+$9.36M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$6.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.76% |
| 2 | Consumer Discretionary | 14.7% |
| 3 | Healthcare | 14.64% |
| 4 | Consumer Staples | 12.4% |
| 5 | Miscellaneous | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$804B
| $35.5M | 6.06% |
+110,200
| New | +$33.9M |
2019 Q4
0 quarters
|
|
2
Target
TGT
$69.7B
| $11.4M | 1.94% |
88,724
+200
| +0.2% | +$23.5K |
2019 Q2
2 quarters
|
|
3
Walmart Inc
WMT
$942B
| $7.95M | 1.36% |
200,628
+51,600
| +35% | +$2.05M |
2018 Q2
6 quarters
|
|
4
Coca-Cola
KO
$400B
| $6.97M | 1.19% |
125,900
+46,800
| +59% | +$2.52M |
2019 Q3
1 quarter
|
|
5
Starbucks
SBUX
$111B
| $6.69M | 1.14% |
76,100
+29,100
| +62% | +$2.48M |
2018 Q4
4 quarters
|
|
|
6
Verizon
VZ
$186B
| $6.68M | 1.14% |
+108,800
| New | +$6.56M |
2019 Q4
0 quarters
|
|
|
7
Lowe's Companies
LOW
$110B
| $6.5M | 1.11% |
+54,300
| New | +$6.21M |
2019 Q4
0 quarters
|
|
8
Roku
ROKU
$22.9B
| $6.35M | 1.09% |
47,400
+8,900
| +23% | +$1.22M |
2019 Q2
2 quarters
|
|
|
9
Procter & Gamble
PG
$369B
| $6.28M | 1.07% |
+50,300
| New | +$6.15M |
2019 Q4
0 quarters
|
|
|
10
Danaher
DHR
$161B
| $5.49M | 0.94% |
+40,372
| New | +$5.1M |
2019 Q4
0 quarters
|
|
11
Biogen
BIIB
$34.7B
| $5.28M | 0.9% |
17,800
+13,500
| +314% | +$3.75M |
2019 Q3
1 quarter
|
|
12
Edwards Lifesciences
EW
$49.8B
| $5.13M | 0.88% |
66,000
+57,300
| +659% | +$4.47M |
2019 Q3
1 quarter
|
|
13
Walt Disney
DIS
$190B
| $4.99M | 0.85% |
+34,500
| New | +$4.82M |
2019 Q4
0 quarters
|
|
14
Microsoft
MSFT
$3.91T
| $4.45M | 0.76% |
28,200
-18,900
| -40% | -$2.78M |
2018 Q2
6 quarters
|
|
15
Charles Schwab
SCHW
$159B
| $4.14M | 0.71% |
87,057
+69,396
| +393% | +$3.06M |
2019 Q1
3 quarters
|
|
16
ResMed
RMD
$33.6B
| $3.97M | 0.68% |
25,598
+5,900
| +30% | +$850K |
2019 Q3
1 quarter
|
|
17
Booking.com
BKNG
$122B
| $3.88M | 0.66% |
47,200
-8,300
| -15% | -$652K |
2019 Q3
1 quarter
|
|
18
Constellation Brands
STZ
$22.2B
| $3.83M | 0.66% |
+20,200
| New | +$3.81M |
2019 Q4
0 quarters
|
|
19
Nutanix
NTNX
$18.1B
| $3.83M | 0.65% |
+122,400
| New | +$3.61M |
2019 Q4
0 quarters
|
|
20
PepsiCo
PEP
$179B
| $3.81M | 0.65% |
+27,872
| New | +$3.79M |
2019 Q4
0 quarters
|
|
21
Ulta Beauty
ULTA
$25.3B
| $3.8M | 0.65% |
+15,000
| New | +$3.67M |
2019 Q4
0 quarters
|
|
22
Garmin
GRMN
$54.8B
| $3.78M | 0.65% |
+38,700
| New | +$3.61M |
2019 Q4
0 quarters
|
|
23
CVS Health
CVS
$118B
| $3.57M | 0.61% |
48,100
-21,600
| -31% | -$1.52M |
2019 Q3
1 quarter
|
|
24
Dollar General
DG
$29.5B
| $3.57M | 0.61% |
22,879
-18,800
| -45% | -$2.98M |
2019 Q3
1 quarter
|
|
25
DocuSign
DOCU
$13.9B
| $3.55M | 0.61% |
47,900
+35,367
| +282% | +$2.43M |
2019 Q3
1 quarter
|
|
Similar funds
MCM
MFG
AFW
HSM
FWM
PIA
CCP
WCM
Bayesian Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Bayesian Capital Management held 830 positions worth $585M, up 11% from $529M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Bayesian Capital Management deployed $17.6M of net new capital in Q4 2019, opening 329 new positions and adding to 104 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $11.3M trimmed.
- Bayesian Capital Management's largest Q4 2019 buy was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
- Bayesian Capital Management added most to Edwards Lifesciences in Q4 2019, an estimated $4.47M increase.
- Bayesian Capital Management's biggest Q4 2019 reduction was Meta Platforms (Facebook), cutting an estimated $11.3M.
- Bayesian Capital Management fully exited Accenture in Q4 2019, selling an estimated $12.8M.
- Bayesian Capital Management's ten largest holdings make up 17% of its $585M portfolio in Q4 2019.
- Bayesian Capital Management opened 329 new positions and closed 252 in Q4 2019.
- Bayesian Capital Management's portfolio value rose 11% quarter-over-quarter to $585M.
Based on Bayesian Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.